Biogen Raises Forecast as Alzheimer’s Drug Leqembi Shows Signs of Growth

Published on 30 Oct 2024 on Bloomberg · via Yahoo Finance

(Bloomberg) -- Biogen Inc. raised its annual earnings guidance after reporting better-than-expected...

Read the rest of the article

Start tracking your investments with Statfolio

Free Report) reported earnings of 3 cents per share in the third quarter of 2024. The Zacks...

Zacks 7 Nov 2024

Biogen Inc. is now projecting better full-year financial results that it was a few months ago as ...

The Business Journals 30 Oct 2024

(Bloomberg) -- Biogen Inc. raised its annual earnings guidance after reporting better-than-expect...

Bloomberg · via Yahoo Finance 30 Oct 2024

Biogen Inc. (NASDAQ:BIIB), a leading biotechnology company, shared its third-quarter financial...

Investing.com 30 Oct 2024

, opens new tab said on Monday insider Robin Kramer will take over as the drugmaker's finance chi...

Reuters 28 Oct 2024

We recently compiled a list of the 10 Oversold Large Cap Stocks To Buy Now. In this article, we a...

Insider Monkey · via Yahoo Finance 20 Oct 2024

We recently compiled a list of the 10 Best QQQ Stocks to Buy According to Analysts. In this artic...

Insider Monkey · via Yahoo Finance 20 Oct 2024

We recently compiled a list of the 10 Worst Performing NASDAQ Stocks in 2024. In this article, we...

Insider Monkey · via Yahoo Finance 19 Oct 2024

Biogen BIIB announced that the European Commission (EC) has granted marketing approval to Qalsody...

Zacks via Yahoo Finance 31 May 2024

Europe Approves Biogen's Tofersen For Adult Patients With Rare Type Of Neurodegenerative Disorder...

Benzinga via Yahoo Finance 31 May 2024